LoginSignup
MoepJunior
@MoepJunior
1J·

Why do positive corporate earnings lead to stock price declines?

4
19 Commentaires
image de profil
jkb92@jkb92
1J
Why is a banana curved?
‱
8
‱
image de profil
Endurance Life@MozartsGeist
1J
@jkb92 Because she wants to grow toward the sun?
‱
3
‱
image de profil
Dividendenopi👮@Dividendenopi
1J
@jkb92 If it were straight, it wouldn't fit in the bowl
‱
5
‱
image de profil
Klein-Anleger@Klein-Anleger
1J
@jkb92 because I wouldn't buy a straight banana, and because Apple has already designed the banana emoji to be round 🍌
‱
4
‱
image de profil
Endurance Life@MozartsGeist
1J
@Klein-Anleger Speaking of Apple, when will we head north again?
‱‱
image de profil
Klein-Anleger@Klein-Anleger
1J
@MozartsGeist They're almost at their all-time high—I don't think they're a bargain right now, but they're not overpriced either

‱
1
‱
image de profil
Endurance Life@MozartsGeist
1J
Just under 10% down over the last 7 days
‱‱
image de profil
Ichbinak63@Ichbinak63
1J
@jkb92 because she had been avoiding the GDR for years.
‱
3
‱
image de profil
jkb92@jkb92
1J
@MozartsGeist "to the sun" haha—that analogy would probably go over best with Novo shareholders
‱
1
‱
image de profil
Seventrader@7Trader
1J
@jkb92 because nobody went into the jungle and straightened them out 😆
‱
4
‱
image de profil
Endurance Life@MozartsGeist
1J
@jkb92 Tomorrow, the sun ☀ might just show its best side.
‱
1
‱
image de profil
EugeneKrabs@Danicx13
1J
I don't get it anymore either. The stock just still can't seem to get going. Every brief rebound gets sold off, and then it goes back down. Positive news doesn't make a difference anymore.
At some point, a stock has to turn around.
I’m holding on because I’m already deep in the red anyway 😂—I’ll probably buy more at some point.
It’s bound to turn around eventually.
‱
3
‱
Markus@MarkusF
1J
@Danicx13 It's a company based in the EU.
Actually, that's pretty normal these days.

And it also has a lot of "investors" who bought in when it was massively undervalued and are cashing out their 20–30% profits in less than 6 months.
‱‱
image de profil
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
1J
‱
2
‱
image de profil
Endurance Life@MozartsGeist
1J
@Get_Rich_or_Die_Tryin Thank you for forwarding this.
‱‱
image de profil
Yoshika 🩋.@Yoshika
1J
However, the only positive figure is the adjusted operating profit before the 6.3 billion in write-downs on the pipeline.
And even the revised forecast for 2026, on an adjusted basis, still shows revenue and operating profit in the range of 0 to -6% compared with 2025.
‱‱
image de profil
Yoshika 🩋.@Yoshika
1J
@Yoshika
And depreciation specifically means that part of the pipeline is worth less than what’s on the books. And the next one has already been announced for Q3, following the ZEUS flop
‱‱
image de profil
BoldTake@BoldTake
1J
The problem:
You’ve developed a drug for a HUGE market that isn’t selling in line with its market potential. Eli Lilli shows that the demand is there.

Patent cliff: There isn’t much potential for a new sales boom right now, and current patents are expiring.

The stock needs a new story


This isn’t meant to be hate! I find the company itself exciting and the price is tempting
 but you run the risk of the stock treading water for a long time here.
‱‱
image de profil
Dirk aus Stade@dirko68
15H
It's a shame that Novo is mentioned specifically here, when the question is surely meant to be more general. Unfortunately, it’s becoming increasingly common for certain expectations to be heavily factored into the stock price beforehand, and then—even when those expectations aren’t quite met—the stock price takes a significant hit despite solid earnings figures.
‱‱
Participez Ă  la conversation
S'inscrireConnexion